StockData
Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG) stock

DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025Score 5/30
$20.76+0.25 (+1.22%)

Close on Nov 18, 2026Market cap $158.52MP/E –Yield –

Bright Minds Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Bright Minds Biosciences's enterprise value was $102.51M on Nov 11, 2026, against $242.38M a year earlier. Over the last 5 years it ranged from -$8.18M to $545.60M, with a median of $2.99M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$102.51M-78.5%
2025Dec 31, 2025$476.30M+214.8%
2024Dec 31, 2024$151.28M+72651.0%
2023Dec 29, 2023$207.94K-62.0%
2022Dec 30, 2022$547.52K-95.8%
2021Dec 31, 2021$12.98M–

More Bright Minds Biosciences figures

See a number that looks wrong?